THE Ministry of Health (MoH), via its Chemistry, Food and Drugs Division, advises of a voluntary nationwide recall of the Docetaxel Injection due to potential presence of particulate matter from the stopper in the drug product.
In a release on Friday, the ministry said the recall applies to two lots of Docetaxel Injection USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials).
The recall was issued by the international distributor, Sagent Pharmaceuticals.
Docetaxel Injection, USP is indicated for the treatment of patients with certain types of cancers. The label and affected lot numbers with Expiration Dates and NDC number can be found in the table below.
Paid political advertisement
The Ministry stated while the recalled products are not registered for use in Trinidad and Tobago, out of an abundance of caution, persons are advised who may be in possession of these recalled products to discontinue use immediately and to return the product to the place of purchase where possible.
